Replies to post #154265 on Avid Bioservices Inc (CDMO)

[asmarterwookie]

Unbelievably Amazing HUH? Kinda like the NASA Peregrine Sounding Rocket...

Ya know...for future space expeditions...

I saw a show about Peregrine Falcons...amazing creatures. A mooma was "defending" against harmless(i think) Pelicans. The Peregrine, a much smaller animal, would grab the Pelicans beak or is it beek, anyway...the maneuver was merely to throw the Pelicans balance off and down they went...one after another.

I wish our Peregrine would grab some squaking birds by the beek or beak....I'll google that now....LOL

BEAK.....how often do you use the word beak? LOL
The funny thing is hat a Pelicans beak probably is called something different...

That's all folks...see yas Top O the Mornin!! A snowy mornin!!!

wook

[eastcoastguy]

Bio, I know its just speculation that Calico may have its eyes on PPHM through the likes of Levinson/Genentech and I would love that scenario. But I think its just as likely that a hedge fund such as Ayer Capital Management may be our preferred buyer. Prior to closing the fund to the public in March 2013 it had up to 5M shares of PPHM and 2000 call options. We know there is interest and history with Jay Venkatesan. I like PPHM's quiet confidence, hiring a deep bench, KOL's, ATM shutdown, start of PH3, and soon to be announced Preferred owner/financial supporter of our Sunrise trial.

Its been pretty quiet around here but it feels like that is going to change soon. My quess is we find out next week and we forge ahead solo...at least for awhile.

Happy New Year!
eastcoastguy

[ws_guy]

Bio ......
Nobody is interested in PPHM , as they have nothing to offer at this point of time. Most BP will wait to see P3 data before stepping in .

P3 will get finance from a Fund in the exchange of preferred shares.

Investment funds seeks preferred share when they are worried about company future prospects.

Preferred share holder has priority over common shareholder.
WS funds are notorious to suck every single drop of common shareholder blood.

So , there is nothing to cheer about all the preferred share talk. The end result is dilution and suffering for common shareholder.

ws